Shares of pharmaceutical giant Amgen (AMGN) are attempting to bounce back after suffering a steep drop of 7.1% yesterday.

BRS spokesperson Manne Krishank gave a strong counter to the claims of Medicover Hospitals that the hospital had no links ...

For Q2, the company’s revenue from the Indian market rose 13.9 per cent to Rs 1,281.7 crore, contributing 37 per cent to ...

Villagers have been fighting for justice for about nine months, yet neither the Chief Minister nor his officials had ...

Telangana attracts ₹36,000 crore investments in life sciences, becoming a global leader in pharmaceutical manufacturing and R ...

Nuvectis Pharma shares fell steeply after updated data from its early-stage study evaluating NXP800 to treat an aggressive type of ovarian cancer showed that a change in the dosing schedule only ...

A ‘Unified Digital Pharmacy Platform’ (UDPP) could serve as a digital healthcare solution for senior citizens, eliminating ...

Glenmark Pharma continued to benefit from its strong position in key chronic therapy areas, including respiratory and dermatology therapeutics, according to its latest, opens new tab annual report.

Source: Supplied. Industry experts, influencers, and pioneers from the world’s top pharmaceutical hubs will gather at the ...

This health news summary explores various pharmaceutical developments including Novo Nordisk's phasing out of insulin pens, a ...

Other top-listed pharmaceutical companies, including Beximco Pharma, ACME Laboratories, and Renata, also failed to achieve the usual double-digit revenue growth seen in the sector since 2014. Only ...

Revenue: US$2.73m (down 33% from 3Q 2023). Net loss: US$162.0m (loss narrowed by 8.5% from 3Q 2023). US$0.86 loss per share ...